Obalon Therapeutics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Obalon Therapeutics, Inc. (OBLN) is 4.27

According to Obalon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.27. This represents a change of 55.85% compared to the average of 2.74 of the last 4 quarters.

Obalon Therapeutics, Inc. (OBLN) Historical Current Ratio (quarterly & annually)

How has OBLN Current Ratio performed in the past?

The mean historical Current Ratio of Obalon Therapeutics, Inc. over the last ten years is 6.51. The current 4.27 Current Ratio has changed 6.47% with respect to the historical average. Over the past ten years (40 quarters), OBLN's Current Ratio was at its highest in in the March 2017 quarter at 19.19. The Current Ratio was at its lowest in in the September 2015 quarter at 0.

Obalon Therapeutics, Inc. (OBLN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Obalon Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Obalon Therapeutics, Inc. (OBLN) Average Current Ratio

How has OBLN Current Ratio performed in the past?

The current Current Ratio of Obalon Therapeutics, Inc. (OBLN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Obalon Therapeutics, Inc. (OBLN) Current Ratio vs. Peers

How is OBLN’s Current Ratio compared to its peers?

Obalon Therapeutics, Inc.’s Current Ratio is greater than Holdco Nuvo Group D.G Ltd. Ordinary Shares (0.05), greater than Regional Health Properties, Inc. (2.80), greater than Greenbrook TMS Inc. (0.51), less than Invitae Corporation (6.41), greater than ViewRay, Inc. (2.36), greater than Xylo Technologies Ltd. (1.14), greater than UpHealth, Inc. (0.63), less than Fresh Tracks Therapeutics, Inc. (6.98), greater than Regional Health Properties, Inc. (2.80), greater than LumiraDx Limited (2.91),

Build a custom stock screener for Obalon Therapeutics, Inc. (OBLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Obalon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Obalon Therapeutics, Inc. (OBLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Obalon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.